Earnings summaries and quarterly performance for HCA Healthcare.
Executive leadership at HCA Healthcare.
Sam Hazen
Chief Executive Officer
Jon Foster
Executive Vice President and Chief Operating Officer
Michael Cuffe
Executive Vice President and Chief Clinical Officer
Michael Marks
Executive Vice President and Chief Financial Officer
Michael McAlevey
Executive Vice President – Chief Legal and Administrative Officer
Board of directors at HCA Healthcare.
Andrea Smith
Director
Hugh Johnston
Director
John Chidsey
Director
Michael Michelson
Independent Presiding Director
Nancy-Ann DeParle
Director
Robert Dennis
Director
Thomas Frist III
Chairman
Wayne Riley
Director
William Frist
Director
Research analysts who have asked questions during HCA Healthcare earnings calls.
Andrew Mok
Barclays
8 questions for HCA
Ann Hynes
Mizuho Financial Group
8 questions for HCA
Pito Chickering
Deutsche Bank
8 questions for HCA
Ryan Langston
TD Cowen
8 questions for HCA
Brian Tanquilut
Jefferies
7 questions for HCA
Joshua Raskin
Nephron Research
7 questions for HCA
Matthew Gillmor
KeyCorp
7 questions for HCA
Benjamin Hendrix
RBC Capital Markets
6 questions for HCA
Scott Fidel
Stephens Inc.
6 questions for HCA
Whit Mayo
Leerink Partners
6 questions for HCA
Justin Lake
Wolfe Research, LLC
5 questions for HCA
Raj Kumar
Stephens
5 questions for HCA
Jason Cassorla
Guggenheim Partners
4 questions for HCA
Lance Wilkes
Sanford C. Bernstein & Co., LLC
4 questions for HCA
Sarah James
Cantor Fitzgerald
4 questions for HCA
Stephen Baxter
Wells Fargo
4 questions for HCA
A.J. Rice
UBS Group AG
3 questions for HCA
Albert Rice
UBS
3 questions for HCA
Craig Hettenbach
Morgan Stanley
3 questions for HCA
Joanna Gajuk
Bank of America
3 questions for HCA
Kevin Fischbeck
Bank of America
3 questions for HCA
Stephen Baxter
Wells Fargo & Company
3 questions for HCA
Anna
Wolfe Research
2 questions for HCA
Ben Hendricks
RBC Capital Markets
2 questions for HCA
Benjamin Mayo
Leerink Partners
2 questions for HCA
Benjamin Rossi
JPMorgan Chase & Co.
2 questions for HCA
Ben Rossi
JPMorgan Chase & Co.
2 questions for HCA
Gabby
Cantor Fitzgerald
2 questions for HCA
Jamie Perse
The Goldman Sachs Group, Inc.
2 questions for HCA
John Ransom
Raymond James
2 questions for HCA
A.J. Rice
UBS
1 question for HCA
Anna Barsanti
Wolfe Research, LLC
1 question for HCA
Craig Haughton
Morgan Stanley
1 question for HCA
Josh Raskin
Nathron Research
1 question for HCA
Meghan Holtz
Jefferies Financial Group Inc.
1 question for HCA
Recent press releases and 8-K filings for HCA.
- HCA guided to 6–9% core EBITDA growth for 2026, incorporating a $600 million–$900 million ACA exchange headwind driven by a 15–20% drop in exchange volume and shifts in coverage and utilization.
- The company’s resiliency program aims to deliver $400 million in savings in 2026 through revenue integrity, asset optimization, and shared-service efficiency improvements, building on its COVID-era framework.
- AI investments are organized across three domains—administrative (short-term), operational (intermediate-term), and clinical (long-term)—to enhance revenue cycle, labor scheduling, and patient-care workflows.
- HCA maintains a network strategy with 14 outpatient access points per hospital, expanding via acquisitions of urgent care centers, freestanding ERs, and ASCs to deepen market coverage.
- Workforce investments include growing Galen College of Nursing from 5 campuses in 2019 to 25 by end-2026 (≈7,000 graduates/year) and expanding GME programs to 5,800 residents across 81 hospitals.
- HCA projects 6%–9% core EBITDA growth for 2026, factoring in a $600 M–$900 M ACA exchange headwind and $400 M of cost savings from its resiliency program.
- The ACA exchange impact model assumes a 15%–20% drop in exchange volume, 15%–20% conversion to employer‐sponsored insurance, a 30% utilization decline among the uninsured, and higher patient dues collectibility risk.
- A multi‐year resiliency program spanning revenue integrity, asset optimization, and fixed/variable cost management targets $400 M in savings in 2026, leveraging shared services, benchmarking, AI, and automation.
- AI efforts are organized across three domains: administrative (short-term rollout via shared services), operational (intermediate-term, e.g., staffing and LOS), and clinical (longer-term, patient-care enhancements).
- Technology investments include upgrading 40 hospitals to Meditech Expanse (full conversion by end-2028) and expanding Galen College of Nursing from 5 campuses in 2019 to 25 by end-2026 (~7,000 annual graduates; 30,000 students goal by 2030).
- HCA expects 6%–9% core EBITDA growth in 2026, while accounting for a $600M–$900M ACA exchange headwind, driven by assumed 15%–20% drop in exchange admissions, 15%–20% conversion to employer coverage, a 30% utilization decline for the uninsured, and patient collection pressures.
- The company’s resiliency program targets $400M in savings in 2026, focusing on revenue integrity, asset optimization, and fixed/variable cost reductions as a multi-year enterprise capability.
- AI strategy spans three domains: administrative (short-term digital product rollouts), operational (intermediate-term workforce and process optimization), and clinical (long-term patient care enhancement); 40 hospitals have upgraded from Meditech Magic to Expanse, with full conversion by end-2028 to support AI development.
- Network expansion delivers 14 outpatient assets per hospital through strategic ASCs, urgent care and freestanding ER acquisitions, while workforce initiatives grow Galen College from 5 to 25 campuses (~7,000 annual graduates) aiming for 30,000 students by 2030, and sustain 5,800 GME residents.
- HCA is live with 50 of 191 hospitals on the MEDITECH Expanse EMR, with full rollout expected by end of 2028, forming a foundation for AI, workflow standardization and cloud-native data management.
- The company models a $600 million–$900 million annual headwind in 2026 from the expiration of enhanced ACA premium tax credits, assuming a 15%–20% conversion of disenrolled exchange members to employer-sponsored coverage; management expects potential further enrollment loss in 2027.
- Capital deployment remains balanced: adding 600–700 beds annually and expanding outpatient access—reaching 14 ambulatory sites per hospital in 2025 en route to a 20-per-hospital target—through hospitals, ASCs, freestanding ERs, urgent care and tuck-in acquisitions.
- Strategic payer partnerships focus on bi-directional digital data exchange (eligibility, claims status), prior authorization streamlining and discharge coordination, complemented by AI-driven denial mitigation and improved physician documentation to enhance revenue cycle efficiency.
- HCA is live on MEDITECH Expanse at 50 of ~191 hospitals (≈1/3 complete), targeting full rollout by end-2028 to standardize data and underpin AI initiatives.
- Expects a $600 million–$900 million 2026 headwind from expiration of enhanced ACA premium tax credits; model assumes 15–20% of disenrollees shift to employer-sponsored insurance and may see multi-year enrollment declines.
- Balanced capital deployment adds 600–700 beds annually and expands outpatient access, aiming for 20 ambulatory sites per hospital (14 achieved by end-2025) through ambulatory surgery centers, freestanding ERs and urgent care.
- Completed full acquisition of Valesco JV, extending internal coverage to 65% of ERs, enhancing control over hospital-based services and supporting further deployment in new markets.
- Growing workforce pipeline via Galen College investment: from 5 nursing campuses in 2019 to 25 by 2026, with goal of 30 campuses by 2030 to address clinical labor needs.
- Digital transformation: MEDITECH Expanse is live in ~50 of 191 hospitals (about one-third complete) with full rollout by end-2028, forming the foundation for AI, standardized data and bolstered cybersecurity; these tech investments are included in 2026 guidance.
- Marketplace subsidy expiration: 2026 guidance factors in a $600 M–$900 M headwind from the lapse of enhanced ACA premium tax credits, driven by exchange effectuation rates and an assumed 15–20% conversion of disenrolled members to employer-sponsored insurance.
- Capacity and outpatient build-out: Allocating capital to add 600–700 beds annually, expand service lines and grow ambulatory access—targeting 20 outpatient sites per hospital (up from 14 at end-2025)—through ASCs, freestanding ERs, urgent cares and tuck-in acquisitions.
- Physician services platform: Fully acquired Valesco JV to internalize ER and hospital-based medicine, now covering 65% of ERs, creating a strategic employment asset for emergency and inpatient care.
- Payer and revenue cycle initiatives: Partnering with major payers for bi-directional digital data exchange (APIs for claims, eligibility), while leveraging Parallon and AI-driven tools to mitigate denials and underpayments, with an emphasis on enhanced physician documentation.
- HCA is advancing AI and digital transformation across three domains—clinical (decision support and reduced admin burden), operational (throughput and labor management) and administrative (supply chain, revenue cycle)—building and scaling use cases enterprise-wide.
- In the revenue cycle, HCA is deploying large language models (in partnership with Palantir and Google) to automate medical-record summarization for peer-to-peer consults, denial appeals and dispute preparation, with beta complete and scale-out slated for 2026.
- Following ACA reforms (EPTC expiration, One Big Beautiful Bill Act and prior admin rules), HCA expects a 15%–20% drop in exchange volumes, ~30% lower utilization among newly uninsured and a $600 M–$900 M negative impact to 2026 adjusted EBITDA.
- Network expansion remains a priority, with 150 freestanding ERs, accelerated urgent care and ambulatory surgery center growth, and clinic build-outs to enhance care continuity and market reach.
- 2026 guidance assumes ~3% adjusted EBITDA growth at midpoint (incorporating ACA and state-payment headwinds and resiliency plans), while maintaining long-term targets of 4%–6% EBITDA growth and 19%–20% margins.
- HCA’s AI and digital transformation efforts are organized into three domains: clinical (≈1/3 of initiatives with multi-year build and human-in-the-loop controls), operational (labor management and throughput tools such as Tempany—live in ~80 hospitals—with a 3–5-year horizon), and administrative (supply chain, revenue cycle, and HR use cases targeting material impacts by 2026–2028).
- Initial AI-enabled throughput improvements supported a 2% reduction in length of stay last year through combined investments in people, processes, and emerging technology tools.
- Revenue cycle AI pilots in 2026 will deploy large language models to summarize medical and administrative records, accelerating peer-to-peer consult prep, automated denial appeals, and dispute resolution support under centralized review.
- 2026 adjusted EBITDA growth is guided at just under 3% at midpoint, factoring in $600–$900 million of ACA reform headwinds and $250–$450 million of state-directed payment impacts, partially offset by resiliency measures.
- Network expansion priorities include 150 freestanding emergency rooms, accelerated urgent care and ambulatory surgery center openings, and community clinic roll-outs to diversify access points and decompress hospital volumes.
- HCA is advancing its digital transformation through AI across three domains—clinical (long-term), operational (3–5 years) and administrative (2026–28)—and has deployed its Tempany labor-management tool in ~80 hospitals to predict staffing demand and optimize schedules.
- The company forecasts exchange volumes will decline 15–20% in 2026, with 80–85% of those losing coverage becoming uninsured and reducing utilization by 30%, resulting in a $600 M–$900 M adjusted EBITDA headwind; additional state-directed payment reforms may add $250 M–$450 M of pressure.
- To drive growth, HCA is expanding its care network via 150 freestanding emergency rooms, urgent care centers, ambulatory surgery centers and community clinics, creating a comprehensive continuum of care for varied acuity and price points.
- Full-year 2026 guidance assumes headwinds will limit adjusted EBITDA growth to ~3% at midpoint; HCA plans to use its resiliency initiatives, AI advances and network optimization to return to its long-term 4–6% growth and 19–20% margin targets over time.
- $400 million resiliency program to offset ACA APTC headwinds (estimated $600 million–$900 million), spanning revenue integrity, throughput optimization, and fixed/variable cost reductions as a multi-year strategic imperative for 2026.
- Monitoring key modeling assumptions—exchange attrition rates, metal tier shifts, and coverage transitions (15%–20% back to ESI)—with initial insights to be provided on the Q1 2026 earnings call.
- 2026 capital allocation includes $5.25 billion–$5.5 billion in CapEx for organic growth and a $10 billion share repurchase authorization, with the majority slated for completion.
- Inpatient occupancy maintained at 70%–75% through adding 600–700 beds annually and length-of-stay initiatives; guidance calls for 2%–3% unadjusted admissions growth in 2026 driven by Medicare, a Medicaid rebound, and commercial volumes.
- Denials activity rose in 2025 but was mitigated via AI-powered revenue cycle and automation investments alongside payer partnerships; administrative efficiency gains expected over the next 2–4 years as digital transformation scales.
Quarterly earnings call transcripts for HCA Healthcare.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
